Report Details:
15 Companies Covered
128 Pages
Topical Corticosteroids Market Growth Highlights
Topical Corticosteroids Market Size was estimated at 4347.23 USD Million in 2024. The Topical Corticosteroids industry is projected to grow from 4668.26 USD Million in 2025 to 8496.08 USD Million by 2035, exhibiting a compound annual growth rate (CAGR) of 6.24% during the forecast period 2025 - 2035.
Increasing prevalence of skin diseases worldwide and lack of awareness in both developed and developing countries are some of the factors that drive the growth of the market. Additionally, increasing geriatric population with skin disease, which in some cases remain untreated for a long period boost the market growth.
Taste the market data and market information presented through more than 125 market data tables and figures spread over 110 pages of the project report. Avail the in-depth table of content TOC & market synopsis on “topical corticosteroids market research report–Global forecast till 2030.”
Major Players in the Topical Corticosteroids Market
Some of the key players in the global market are AstraZeneca plc., GlaxoSmithKline plc., Merck & Co., Inc., Pfizer Inc., Sandoz AG (Novartis AG), Sanofi S.A., Actimis Pharmaceuticals, Valeant Pharmaceuticals, Almirall, S.A, and Zylera Pharmaceuticals.
Topical Corticosteroids Market Regional Analysis
The global topical corticosteroids market consists of four regions: the Americas, Europe, Asia Pacific, and the Middle East & Africa.
The Americas dominates the global topical corticosteroids market. It comprises of two regions namely North America and South America. North America is the largest market owing to rising prevalence of skin diseases in the American counties and increasing geriatric population with skin related diseases. According to the American Academy of Dermatology, ~50% of Americans over age 65 have one or other forms of skin diseases.
In Europe, extensive demand for skin care and topical products to treat skin diseases drives the demand for topical corticosteriods. Moreover, increasing expenditure in healthcare domain and investment in the research & development of new treatment methods for skin related diseases will fuel to the growth of the market.
Asia Pacific is the fastest growing and potential market for the topical corticosteroids due to increasing number of dermatology clinics and rising prevalence of skin related diseases in the developing countries. Furthermore, government support and encouragement to healthcare domain, and favorable government policies for pharmaceuticals companies likely to drive the growth of this market over the review period.
The Middle East & Africa is expected witness steady growth due to rising demand for primary healthcare services such as new and advanced treatment methods in healthcare domain.
Segmentation
The global topical corticosteroids market is segmented on the basis of type of formulation. it is segmented into ointments, creams, and others.
On the basis of type of potency class it is segmented into ultra-high, high, moderate, and low. The ultra-high is further segmented into clobetasol propionate, and diflorasone diacetate. The high segment is further segmented into amcinonide, betamethasone dipropionate, desoximetasone, fluocinonide, halcinonide, and others. The moderate segment is further segmented into desoximetasone, fluocinolone acetonide, fludroxycortide, hydrocortisone valerate, triamcinolone acetonide, and others. And the low segment is further segmented into betamethasone valerate, desonide, fluocinolone acetonide, and others.
On the basis of treatment, it is segmented into contact dermatitis, insect stings, psoriasis, eczema, and others.
On the basis of end user, the market is segmented into hospitals, dermatology clinics, pharmacies, and others.
